NIAID Influenza Immunity Research
Helps NIAID Influenza Immunity Research for establish longitudinal infant cohorts studying how initial influenza exposure shapes lasting immunity and informs.
RFA-AI-27-019 funds the establishment or continuation of longitudinal infant cohorts to determine how initial and repeated natural influenza infections and vaccinations shape infant and childhood immunity. The goal is to understand immune imprinting dynamics and provide data to facilitate design of durable, broadly protective universal influenza vaccines. Activity code U01 = Cooperative Agreement. Three awards of up to $3M each from a total pool of $9.6M. Single-cycle RFA with deadline June 4, 2026. Foreign organizations ARE eligible — one of a small set of specifically designated international collaboration NOFOs.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.